FDA Labelling Medical Records 
The Checkup by Singlecare
JULY 15, 2025
Weight loss drugs have been around since the 1930s, but they saw a recent surge in popularity after the Food and Drug Administration (FDA) approved three GLP-1 receptor agonists for weight loss: Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide). These are the brand names that are FDA approved to treat Type 2 diabetes.
STAT
SEPTEMBER 13, 2024
Elevance Health’s Anthem Blue Cross Blue Shield requested money from health-care providers and alleged they falsified patient medical records in ways that led the insurer to cover the medications. As with company drug advertisements, social-media posts sponsored by drug makers are required by the FDA to cite the risks.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 20, 2022
On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. However, the American Medical Association (AMA) released a statement warning that while most patients benefit from Paxlovid, it is not for everyone.
The Checkup by Singlecare
JUNE 28, 2024
Ozempic (semaglutide) is a brand-name injectable prescription medication administered once weekly. It’s in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, approved by the Food and Drug Administration (FDA) to manage blood sugar levels in adults with Type 2 diabetes when combined with diet and exercise.
The FDA Law Blog
OCTOBER 2, 2023
Sasinowski — This time last year, we wrote about a long-overlooked FDA statutory authority and wondered if this provision, known colloquially as the “single study plus confirmatory evidence” pathway, was having a moment (previous post here ). Valentine & Frank J.
The Checkup by Singlecare
DECEMBER 27, 2023
However, a later study disproved the connection by looking at patients’ medical records. Safety measures while using scopolamine Although the Food and Drug Administration (FDA) has not mandated any boxed warnings for scopolamine, there are a few safety measures to be aware of when using the patches.
The Checkup by Singlecare
SEPTEMBER 11, 2024
Long-term Long-term Who typically uses the medication? Adults Adults Conditions treated by propranolol and metoprolol The Food and Drug Administration (FDA) has approved propranolol for more conditions than metoprolol. Off-label uses may include treatment of atrial fibrillation, migraine, and essential tremor.
Expert insights. Personalized for you.
52 
Let's personalize your content